Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1476-5454

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy ; day:26 ; month:12 ; year:2022 ; pages:1-6
Eye ; (26.12.2022), 1-6

Creator: Khandhadia, Samir
Thulasidharan, Suresh
Hoang, Nguyen Thuy Vy
Ibrahim, Sameh Alkhalili
Ouyang, Yanling
Lotery, Andrew J.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41433-022-02370-2

URN: urn:nbn:de:101:1-2023030721272796435957

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Khandhadia, Samir
Thulasidharan, Suresh
Hoang, Nguyen Thuy Vy
Ibrahim, Sameh Alkhalili
Ouyang, Yanling
Lotery, Andrew J.
SpringerLink (Online service)

Other Objects (12)

Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Single-session bilateral reduced-settings photodynamic therapy for bilateral chronic central serous chorioretinopathy

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy

Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy

Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy

Exome sequencing in patients with chronic central serous chorioretinopathy

Predictive risk scores for visual prognosis after photodynamic therapy for central serous chorioretinopathy

Brachytherapy for Central Serous Chorioretinopathy

Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Single-session bilateral reduced-settings photodynamic therapy for bilateral chronic central serous chorioretinopathy

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy

Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy

Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy

Exome sequencing in patients with chronic central serous chorioretinopathy

Predictive risk scores for visual prognosis after photodynamic therapy for central serous chorioretinopathy

Brachytherapy for Central Serous Chorioretinopathy

Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Single-session bilateral reduced-settings photodynamic therapy for bilateral chronic central serous chorioretinopathy

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy

Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy

Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy

Exome sequencing in patients with chronic central serous chorioretinopathy

Predictive risk scores for visual prognosis after photodynamic therapy for central serous chorioretinopathy

Brachytherapy for Central Serous Chorioretinopathy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Single-session bilateral reduced-settings photodynamic therapy for bilateral chronic central serous chorioretinopathy

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy

Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy

Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy

Exome sequencing in patients with chronic central serous chorioretinopathy

Predictive risk scores for visual prognosis after photodynamic therapy for central serous chorioretinopathy

Brachytherapy for Central Serous Chorioretinopathy

Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Single-session bilateral reduced-settings photodynamic therapy for bilateral chronic central serous chorioretinopathy

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy

Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy

Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy

Exome sequencing in patients with chronic central serous chorioretinopathy

Predictive risk scores for visual prognosis after photodynamic therapy for central serous chorioretinopathy

Brachytherapy for Central Serous Chorioretinopathy

Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Single-session bilateral reduced-settings photodynamic therapy for bilateral chronic central serous chorioretinopathy

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy

Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy

Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy

Exome sequencing in patients with chronic central serous chorioretinopathy

Predictive risk scores for visual prognosis after photodynamic therapy for central serous chorioretinopathy

Brachytherapy for Central Serous Chorioretinopathy

Related objects

Reset password